are collected locally using a CDC-provided semi-standard template. Data are submitted without personal identifiers through a secure, online, CDC-supported system. CDC uses these data for monitoring and evaluation of HIV testing and HIV-related service delivery.
Valid HIV TEs were defined as tests for which either a test technology (e.g., conventional, rapid, nucleic acid amplification, or other testing) or test result (positive, negative, indeterminate, or invalid) was reported. Persons who tested HIV-positive but did not report a previous HIV-positive test result were categorized as new positives. HIV service delivery among these persons included linkage to HIV medical care (i.e., attendance at first medical appointment), referral and interview for partner services (i.e., to help persons living with HIV notify sex and drug-injecting partners of possible HIV exposure, to offer services that can protect the health of partners, and to prevent sexually transmitted disease reinfection) (4) , and referral to HIV prevention services (i.e., services or interventions directly aimed at reducing the risk for transmitting or acquiring HIV) (5) .
Analyses included data submitted to CDC as of June 2, 2014, which were stratified by age, sex, U.S. Census region, and selected target populations (MSM, heterosexual males, and heterosexual females). § . † An HIV testing event is one or more HIV tests performed to determine a person's HIV status. During one TE, a person might be tested once (e.g., one rapid test or one conventional test) or multiple times (e.g., one rapid test followed by one conventional test to confirm a preliminary HIV-positive test result). Valid HIV TEs were defined as tests for which either a test technology (conventional, rapid, nucleic acid amplification, or other testing) or test result (positive, negative, indeterminate, or invalid) was reported. § MSM are males who reported male-to-male sexual contact in the past 12 months. Heterosexual males are males who only reported contact with a female in the past 12 months. Heterosexual females are females who only reported contact with a male in the past 12 months. ¶ A health care setting is defined as a site that provides medical diagnostic and treatment services (e.g., inpatient facilities, outpatient facilities, and emergency departments). A non-health care setting is a site that does not provide medical diagnostic and treatment services (e.g., HIV counseling and testing sites and community settings). ** Other target populations and missing data among blacks accounted for 31.0%
of HIV testing events (transgender = 0.4%, persons who inject drugs = 1.1%, persons not reporting sex with male or female or injection drug use (i.e., no risk behavior) = 9.9%, and missing = 19.6%). (Table 1) .
New positives accounted for 0.64% (9,571 of 1,506,016) of TEs among blacks. Among blacks, the HIV positivity for new positives was highest among MSM (9.6%). Although MSM accounted for 8.8% (37,222 of 424,497) of HIV TEs among blacks, they accounted for 37.3% (3,570 of 9,571) of new positive blacks. Among new positive blacks, 53.5% were linked to medical care within any timeframe after their HIV diagnosis; 44.5% were linked to medical care within 90 days; 65.8% were referred to HIV partner services; 46.4% were interviewed for HIV partner services, and 53.6% were referred to HIV prevention services. HIV service delivery was generally comparable by age group and sex, but the Midwest and South lagged in HIV service delivery. Overall, a higher percentage of new positive black MSM than heterosexual males and females were linked to HIV medical care, referred to and interviewed for HIV partner services, and referred to HIV prevention services ( Table 2 ).
Discussion
Blacks are disproportionately affected by HIV. In 2011, blacks accounted for 41% of all persons living with HIV in the United States (1). In 2012, the rate of HIV diagnoses was 58.3 per 100,000 for blacks, in comparison with 18.5 for HIV testing and knowledge of HIV status are the gateway to important prevention services, and for HIV-positive persons, services along the HIV continuum of care. Early initiation and adherence to antiretroviral therapy has substantial medical benefits for HIV-positive persons and prevention benefits by reducing HIV transmission to HIV-negative partners up to 96% (2, 3) . Therefore, in addition to identifying new HIV-positive persons, it is critical to ensure all HIV-positive persons are linked to HIV medical care and receive necessary HIV prevention services. The National HIV/AIDS Strategy (8) has a goal for 2015 that 85.0% of persons newly diagnosed with HIV are linked to HIV medical care within 90 days of diagnosis. The current finding of 44.5% for linkage within 90 days suggests that linkage among blacks needs to be significantly improved to meet the National HIV/AIDS Strategy goal. Because rates of referrals to HIV partner services and HIV prevention services ranged from 46.4% to 65.8%, referrals to these services also could be improved.
The findings in this report are subject to at least five limitations. First, because of missing data, the service delivery data are an underestimate and represent the minimum percentage achieved, particularly for linkage to care. Second, data for target populations are only required in non-health care settings and for TEs resulting in an HIV-positive result in health care settings (28% of TEs among blacks). Therefore, results are underreporting the number of TEs that are being conducted among these populations. Third, the percentage of missing data (19.6%) is high among target populations. Fourth, because this report focuses only on some CDC-funded HIV TEs and does not represent all HIV tests conducted in the United States, these findings might not be generalizable to the entire United States. Finally, because self-report was used to identify a new HIV diagnosis, the number of new positives reported likely represents an overestimation of new positives. Given the importance of programmatic data for effective public health monitoring and evaluation, continued technical assistance is needed to help grantees improve the completeness and accuracy of data.
Continued efforts to expand routine screening as recommended by the U.S. Preventive Services Task Force (9) and CDC guidelines (10) and to target HIV testing services toward populations at high risk, such as MSM, can help identify HIVpositive persons whose infection is undiagnosed, particularly in jurisdictions with the highest HIV prevalence among blacks. Programmatic efforts to increase prevention efforts among HIV-negative persons also are critical to reduce their risk for HIV infection. Finally, linkage to care and behavioral prevention activities for HIV-positive persons are critical to ensure receipt of key services to improve their health and to prevent HIV transmission to their partners (5) .
